PrimeVigilance

You are here: PrimeVigilance

Guildford, UK 15 September 2011, PrimeVigilance is pleased to report that Giovanni Furlan,  Director of Pharmacovigilance Consulting and QPPV, has participated in the writing of three technical papers. PrimeVigilance is committed to participating in discussions at the forefront of developments in the field of pharmacovigilance and welcomes questions and comments from interested parties.

G Furlan: "Integrating Signal detection the Pharmacovigilance System: Key Practical Aspects from the CIOMS VIII Report" DIA Global Forum August 2011; Vol3, Issue 4, page 27-29

http://www.globalforum-digital.org/globalforum/20110809#pg30

S.Douglas, G.Furlan: "The Developmental Safety Update Report. The New Way to Drug Safety or a Born-again Old Report? " DIA Global Forum 2011, Vol3, Issue 4, page 37-42

http://www.globalforum-digital.org/globalforum/20110809#pg40

Please note that to access the articles though the links you need user ID and password (only for DIA members)

Abstract in press:

G Furlan: "Using Resources for Scientific Driven Pharmacovigilance: Switching from Many Product Safety Documents to the Product Safety Master File." Drug Safety 2011 (in press)

The abstract will be the topic of a presentation at Annual ISOP (International Society of Pharmacovigilance) Istanbul 26-28 October 2011.

PrimeVigilance Ltd
Phone: +44 (0) 1483 688 349
Fax: +44 (0) 1483 688 348

info@primevigilance.com

www.primevigilance.com

About Prime Vigilance

PrimeVigilance was set up in 2008 as a joint venture between Dr. Elliot Brown and Dr. Miroslav Reljanovic, the founder of the Ergomed Group. These two experts have formed a UK-registered multinational company which provides an innovative, top quality and cost-effective safety operation for small- and medium- sized pharmaceutical and biotechnology companies.

PrimeVigilance already has an established international footprint and a heritage of excellence and leadership. Dr. Elliot Brown's existing consultancy has an enviable reputation of a decade in PV, with a network of expert associates spanning three continents. These include former senior regulators and consultants with extensive industry experience. To complement this top-level, global consultancy support, the Ergomed Group brings an experienced operational dimension to the PrimeVigilance offering. With offices in the UK, Germany, Southern and Eastern Europe, Russia, the USA and the Middle-East, the Ergomed Group is a quality-focused organisation with outstanding staff and several years experience with the ARISg safety database and clinical safety management.

PrimeVigilance fills the gap between the large multinational CROs that do not provide a service geared towards post-marketing surveillance for small and medium sized companies, and the small service providers that do not have the critical mass, expertise or wide international presence needed to reassure that patients and products will be adequately protected.

For more information contact PrimeVigilance today.